Cascade of Events Leading to Prion Disease Described

Summary: A new study describes two distinct stages of prion disease.

Source: Elsevier Health Sciences.

New experiments in mice now enable researchers to evaluate disease progression and potential therapeutic interventions in vivo, according to a new report in the American Journal of Pathology.

Prion diseases are deadly neurodegenerative disorders in humans and animals that are characterized by misfolded forms of prion protein (PrP). Development of effective treatments has been hampered by the lack of good experimental models. In a new study published in The American Journal of Pathology, researchers describe the distinct stages of prion disease in the mouse retina and define an experimental model to specifically test therapeutic approaches.

“This work was done in collaboration with the USDA Agricultural Research Service and is an excellent example of how animal disease research can be leveraged to benefit human health,” commented Heather West Greenlee, PhD, an Associate Professor in the Department of Biomedical Sciences at the Iowa State University College of Veterinary Medicine (Ames IA). “It provides important insights into the timeline for key pathologic milestones of prion disease in the retina and a model to study mechanisms of disease progression and evaluate therapeutic interventions.”

The study used an experimental mouse model of the prion disease scrapie to determine the temporal relationship between the transport of misfolded prion protein (PrPSc) from the brain to the retina, the accumulation of PrPSc in the retina, the inflammatory response of the surrounding retinal tissue, and the loss of neurons.

It is believed that transmissible spongiform encephalopathy (TSE) progression depends on the spread of misfolded protein from one central nervous system structure to another. The investigators injected mouse-adapted scrapie into the brains of mice and studied the movement of misfolded prion protein from the brain into the retina via the optic nerve for up to 153 days post-inoculation (dpi), when clinical disease becomes apparent.

By studying prion disease in the retina, which is relatively isolated from the brain, researchers were able to determine the time lag between stages of the disease process and were able to sequentially detect seeding of misfolded protein in the retina at 60 dpi, followed by accumulation of PrPSc and activation of retinal glia at 90 days, activation of microglia at 105 dpi, and retinal neuronal death at 120 dpi.

Image shows tissue with scrapie.
The study used an experimental mouse model of the prion disease scrapie to determine the temporal relationship between the transport of misfolded prion protein (PrPSc) from the brain to the retina, the accumulation of PrPSc in the retina, the inflammatory response of the surrounding retinal tissue, and the loss of neurons. NeuroscienceNews.com image is credited to Gillian McGovern, Martin Jeffrey.

Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a transmissible protein misfolding disease, which makes them a good model to study common aspects of these diseases. “Not only will this work contribute to the development of therapy to treat prion disease, but it may also provide important insights into which therapies may be effectively applied to the treatment of other protein misfolding diseases, including Parkinson disease and Alzheimer disease,” explained Dr. Greenlee.

Using this information, it is now possible to evaluate a potential therapy for its ability to interfere with accumulation of protein misfolding, to suppress damaging neuroinflammation, or to prevent death of neurons.

Prion diseases include Creutzfeldt-Jakob disease and kuru in humans, scrapie in sheep, mad cow disease in cows, and chronic wasting disease in deer.

[divider]About this neurology research article[/divider]

Funding: Funding for this research was supported by the US Department of Agriculture, National Animal Disease Center, Iowa State University College of Veterinary Medicine.

Source: Eileen Leahy – Elsevier Health Sciences
Image Source: This NeuroscienceNews.com image is credited to Gillian McGovern & Martin Jeffrey, licensed CC BY 2.5.
Original Research: Abstract for “Temporal Resolution of Misfolded Prion Protein Transport, Accumulation, Glial Activation, and Neuronal Death in the Retinas of Mice Inoculated with Scrapie” by M. Heather West Greenlee, Melissa Lind, Robyn Kokemueller, Najiba Mammadova, Naveen Kondru, Sireesha Manne, Jodi Smith, Anumantha Kanthasamy, and Justin Greenlee in American Journal of PAthology. Published online August 9 2016 doi:10.1016/j.ajpath.2016.05.018

[divider]Cite This NeuroscienceNews.com Article[/divider]

[cbtabs][cbtab title=”MLA”]Elsevier Health Sciences. “Cascade of Events Leading to Prion Disease Described.” NeuroscienceNews. NeuroscienceNews, 9 August 2016.
<https://neurosciencenews.com/prion-disease-cascade-4815/>.[/cbtab][cbtab title=”APA”]Elsevier Health Sciences. (2016, August 9). Cascade of Events Leading to Prion Disease Described. NeuroscienceNews. Retrieved August 9, 2016 from https://neurosciencenews.com/prion-disease-cascade-4815/[/cbtab][cbtab title=”Chicago”]Elsevier Health Sciences. “Cascade of Events Leading to Prion Disease Described.” https://neurosciencenews.com/prion-disease-cascade-4815/ (accessed August 9, 2016).[/cbtab][/cbtabs]


Abstract

Temporal Resolution of Misfolded Prion Protein Transport, Accumulation, Glial Activation, and Neuronal Death in the Retinas of Mice Inoculated with Scrapie

Currently, there is a lack of pathological landmarks to describe the progression of prion disease in vivo. Our goal was to use an experimental model to determine the temporal relationship between the transport of misfolded prion protein (PrPSc) from the brain to the retina, the accumulation of PrPSc in the retina, the response of the surrounding retinal tissue, and loss of neurons. Retinal samples from mice inoculated with RML scrapie were collected at 30, 60, 90, 105, and 120 days post inoculation (dpi) or at the onset of clinical signs of disease (153 dpi). Retinal homogenates were tested for prion seeding activity. Antibody staining was used to assess accumulation of PrPSc and the resulting response of retinal tissue. Loss of photoreceptors was used as a measure of neuronal death. PrPSc seeding activity was first detected in all samples at 60 dpi. Accumulation of PrPSc and coincident activation of retinal glia were first detected at 90 dpi. Activation of microglia was first detected at 105 dpi, but neuronal death was not detectable until 120 dpi. Our results demonstrate that by using the retina we can resolve the temporal separation between several key events in the pathogenesis of prion disease.

“Temporal Resolution of Misfolded Prion Protein Transport, Accumulation, Glial Activation, and Neuronal Death in the Retinas of Mice Inoculated with Scrapie” by M. Heather West Greenlee, Melissa Lind, Robyn Kokemueller, Najiba Mammadova, Naveen Kondru, Sireesha Manne, Jodi Smith, Anumantha Kanthasamy, and Justin Greenlee in American Journal of PAthology. Published online August 9 2016 doi:10.1016/j.ajpath.2016.05.018

[divider]Feel free to share this Neuroscience News.[/divider]

Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive the latest neuroscience headlines and summaries sent to your email daily from NeuroscienceNews.com
We hate spam and only use your email to contact you about newsletters. We do not sell email addresses. You can cancel your subscription any time.